논문실적
Home › 연구실적 › 논문실적
- 380Large language model usage guidelines in Korean medical journals: a survey using human-artificial intelligence collaboration
Ahn S · J Yeungnam Med Sci. 42:14 / 2025 · 2025 IPPM
- 379Barriers and opportunities in biobank utilization: insights from a 3-year repeated cross-sectional survey of the Female Breast and Genital Disease with Microbiome Biobank Network in South Korea
Ahn S, Cho HJ, Kang MS, Seo AN, Kim L, Choi KU, Roh MS, Kim EY · J Yeungnam Med Sci. 42:46 / 2025 · 2025 IPPM
- 378The population pharmacokinetics of dolutegravir co-administered with rifampicin in Thai people living with HIV: Assessment of alternative dosing regimens
Punyawudho B, Chanruang A, Ueaphongsukkit T, Gatechompol S, Ubolyam S, Cho YS, Shin JG, Avihingsanon A · CPT Pharmacometrics Syst Pharmacol. 14(1):95-104 / 2025.01 · 2025 cPMTb
- 377Optimization of meropenem continuous infusion based on Monte Carlo simulation integrating with degradation study
Tien NTN, Binh VN, Ha PTT, Lan DTN, Cho YS, Long NP, Shin JG, Anh NH(Jr), Quan TA, Tuan DN, Tiep NK, Thach PT, Anh NH, Hoa VD · PLoS One. 23;19(12):e0313764 / 2024.12 · 2024 cPMTb
- 376Time-course cross-species transcriptomics reveals conserved hepatotoxicity pathways induced by repeated administration of cyclosporine A
Tien NTN, Anh TT, Yen NTH, Anh NK, Nguyen HT, Kim HS, Oh JH, Kim DH, Long NP · Toxicol Mech Methods. 34(9):1010-1021 / 2024.11 · 2024 IPPM
- 375Combining metabolomics and machine learning to discover biomarkers for early-stage breast cancer diagnosis
Anh NK, Lee A, Phat NK, Yen NTH, Thu NQ, Tien NTN, Kim HS, Kim TH, Kim DH, Kim HY, Phuoc Long N · PLoS One. 19(10):e0311810 / 2024.10 · 2024 IPPM
- 374Comparison of drug-induced liver injury risk between propylthiouracil and methimazole: A quantitative systems toxicology approach
He Q, Li M, Ji P, Zheng A, Yao L, Zhu X, Shin JG, Lauschke VM, Han B, Xiang X · Toxicol Appl Pharmacol. 491:117064 / 2024.10 · 2024 IPPM
- 373Prediction of Pharmacokinetic Drug-Drug Interactions Involving Anlotinib as a Victim by Using Physiologically Based Pharmacokinetic Modeling
Bu F, Cho YS, He Q, Wang X, Howlader S, Kim DH, Zhu M, Shin JG, Xiang X · Drug Des Devel Ther. 15:18:4585-4600 / 2024.10 · 2024 cPMTb
- 372The transformative impact of large language models on medical writing and publishing: current applications, challenges and future directions
Ahn S · Korean J Physiol Pharmacol. 28(5):393-401 / 2024.09 · 2024 IPPM
- 371Drug-Drug Interactions between COVID-19 and Tuberculosis Medications: A Comprehensive Review of CYP450 and Transporter-Mediated Effects
Jony MR, Ahn S · Pharmaceuticals (Basel). 17(8):1035 / 2024.08 · 2024 IPPM
- 370Discovery of urinary biosignatures for tuberculosis and nontuberculous mycobacteria classification using metabolomics and machine learning
Anh NK, Phat NK, Thu NQ, Tien NTN, Eunsu C, Kim HS, Nguyen DN, Kim DH, Long NP, Oh JY · Sci Rep. 14(1):15312 / 2024.07 · 2024 IPPM
- 369Data science through natural language with ChatGPT's Code Interpreter
Ahn S · Transl Clin Pharmacol. 32(2):73-82 / 2024.06 · 2024 IPPM
- 368Enhancing drug administration flexibility: evaluation of pharmacokinetic properties of tegoprazan orally disintegrating tablet (ODT) administered via nasogastric tube or oral dosing
Kim HS, Choi YK, Oh MK, Cho YS, Ghim JL · Transl Clin Pharmacol. 32(2):98-106 / 2024.06 · 2024 cPMTb
- 367Cyclosporine A-induced systemic metabolic perturbations in rats: A comprehensive metabolome analysis
Yen NTH, Tien NTN, Anh NTV, Le QV, Eunsu C, Kim HS, Moon KS, Nguyen HT, Kim DH, Long NP · Toxicol Lett. 395:50-59 / 2024.05 · 2024 IPPM
- 366Metabolic phenotyping and global functional analysis facilitate metabolic signature discovery for tuberculosis treatment monitoring
Anh NK, Yen NTH, Tien NTN, Phat NK, Park YJ, Kim HS, Vu DH, Oh JY, Kim DH, Long NP · Biochim Biophys Acta Mol Basis Dis. 1870(4):167064 / 2024.04 · 2024 IPPM